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CD1—The Pathology Perspective
S.M. RHIND
Department of Veterinary Pathology, Royal (Dick) School of Veterinary Studies, University of Edinburgh, Easter Bush
Veterinary Centre, Midlothian, UK
Abstract. CD1 molecules are a family of cell surface-associated glycoproteins now recognized as having
a role in antigen presentation. These glycoproteins are distinct from yet have some similarities to classical major
histocompatibility complex class I and class II molecules. The role of these molecules has been studied in detail
over recent years, with an explosion of interest following the demonstration that they can present nonprotein
antigens to certain subpopulations of T cells. The purpose of this paper is to provide an overview of current
knowledge of the function of the CD1 family with speciﬁc emphasis on the potential role in the pathogenesis
of certain diseases. Although much of the current research in this ﬁeld has inevitably concentrated on mice and
humans, this work also has potential signiﬁcance for veterinary species.
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The CD1 family comprises ﬁve distinct genes, A–
E, which are variably conserved across the species.
The family can be broadly divided into two groups—
the CD1A-C group (group 1) and the CD1D group
(group 2). Sequencing of CD1E (only identiﬁed in hu-
mans and guinea pigs to date) indicates that this is an
intermediate group with similarities to both group 1
and group 2.13,16 Mice and rats only possess members
of the CD1D group, and humans, sheep, and rabbits
possess members of both groups. Recent molecular
studies in the pig have identiﬁed a gene (pCD1.1) that
is relatively dissimilar to other CD1 isotypes and
moreover contains a major histocompatibility complex
(MHC) class I-like cytoplasmic tail.15 A summary of
current knowledge of CD1 genes and proteins across
species is presented in Table 1. With the apparent ex-
ception of the guinea pig,16 there is evolutionary con-
servation of CD1d antigens, consistent with a key role
for these molecules in the immune response.11 More
recent studies have begun to extend the initial immu-
nologic characterization of these molecules and to ad-
dress the signiﬁcance of this axis of the immune sys-
tem in the pathogenesis of a range of diseases.
The details of the immunology of these molecules
have been extensively reviewed recently.9,36,37 Here, I
provide only a brief overview as a prerequisite to the
understanding of the pathologic signiﬁcance of CD1.
I then review the role of CD1 in disease pathogenesis
with more detailed discussion of the implications and
potential signiﬁcance for the future in terms of veter-
inary pathology.
CD1 Structure and Function
A highly relevant feature of these molecules in their
remarkable lack of polymorphism, totally unlike clas-
sical MHC class I and class II molecules, which are
inherently polymorphic. In the early days of CD1 re-
search, this lack of variability in MHC-related mole-
cules was perceived to reﬂect possible functional re-
dundancy of the population27; however, it is now clear
that this feature provides vital clues to the role of these
molecules. CD1 molecules are structurally similar to
MHC molecules, in particular to MHC class I mole-
cules, with which they share a closely similar exon
arrangement and corresponding morphology (Fig. 1).
The recent resolution of the crystal structure of mouse
CD1 demonstrated that the structure is more closely
related to that of MHC class I than to that of MHC
class II. The binding groove, although signiﬁcantly
narrower, is substantially larger because of increased
depth and it has only two major pockets that are almost
completely hydrophobic.56 This structure provides a
classical antigen-presenting architecture allowing frag-
ments of antigenic material to be presented on the cell
surface, where appropriate T cells can be triggered on
recognition of the antigen.
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Table 1. Interspecies summary of the documented presence (X) of members of the CD1 family.
Species
Genes
CD1A CD1B CD1C CD1D CD1E
Proteins
CD1a CD1b CD1c CD1d CD1e
Human
Mouse
Rat
Rabbit
Guinea pig
Sheep
Cow
Pig
Horse
Dog
Cat
X
X†
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X
X*
X
X
X*
X
X
X*
X*
X*
X
X*
X
X
X
X
X
* Data obtained on the basis of mAb cross-reactivity (speciﬁc isotype identity not proven).
† The porcine gene, pCD1.1, is most similar to human CD1A but is nevertheless relatively dissimilar to other CD1 molecules.15
Fig. 1. Exon arrangement of CD1 and translation to pro-
tein structure showing antigen-binding groove (ABG) cre-
ated by the alpha 1 and alpha 2 domains. Note also the
noncovalent association with !2-microglobulin. TM " trans-
membrane; Cyt " cytoplasmic; UT " untranslated.
T-cell Recognition of CD1
There has been much work carried out on the nature
of the T cells capable of recognizing CD1, a detailed
discussion of which is outside the scope of this review;
however, the gamma delta (#$), double negative (DN),
and natural killer (NK) T cells have all been linked
with recognition of CD1 molecules. The key feature
common to many of these cells is expression of a rel-
atively invariant T-cell receptor (consistent with rec-
ognition of conserved antigen and an invariant presen-
tation molecule). The DN subset is characterized by
lack of expression of both CD4 and CD8 molecules.
These cells can express either %! or #$ receptors and
many are relatively invariant.
The #$ T-cell population has attracted much interest
with regard to potential recognition of CD1 molecules.
These cells have marked interspecies differences in
numbers and location and are present in notably large
numbers in young ruminants.21 In humans, a major
subset of #$ T cells recognize CD1c molecules,48 al-
though signiﬁcant functional studies on the relation-
ship between CD1 molecules and #$ & cells have yet
to be carried out in animals. NK T cells are a spe-
cialized population of T cells that coexpress receptors
of the NK lineage. These cells are distinct from natural
killer cells, with which they share some common re-
ceptors.8 The NK T cells have a remarkable capacity
to rapidly secrete large amounts of cytokines (notably
Interleukin 4 [IL-4] and Interferon # [IFN#]) and can
thus rapidly regulate Th1/Th2 differentiation.7 Many
of these cells are reactive to CD1 molecules.6 A further
intriguing feature of these cells is autoreactivity; ex-
ogenous antigen is not always required to elicit a CD1-
restricted response.
The functional relevance of this CD1 recognition by
speciﬁc T-cell subsets provides the immune system
with a mechanism for rapid response to nonpoly-
morphic molecules, consistent with a key role in innate
immunity prior to the onset of the deﬁnitive acquired
immune response.
CD1 Expression
In broad terms, CD1 expression can be divided into
two categories on the basis of anatomic localization:
strong expression on cortical thymocyte populations
and expression on a variety of antigen-presenting cells
(APCs), notably dendritic cells, B cells, and mono-
cytes. There is interisotype and interspecies variation
in CD1 expression, and monoclonal antibodies (mAbs)
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can be used to readily demonstrate this feature across
many species. With the exception of the mouse (which
for reasons of limited expression is not a good model
for the system), the animal species with one of the best
characterized CD1 families is the sheep, in which stud-
ies of expression at the cellular and molecular level
have been carried out.18,39,40 CD1 molecules have been
identiﬁed using mAbs in other species, including the
cat,53 dog,34,35 pig,17,42 and horse.45 Most CD1 mole-
cules are expressed at high levels in the thymus. Using
the mAb IAH-CC20 (which recognizes CD1b23),
strong expression of CD1 is evident in cortical thy-
mocytes of ruminants, dogs, and horses (Fig. 2).
Figure 3 demonstrates CD1 staining on canine den-
dritic cells using the mAb IAH-CC20. In addition to
the use of mAbs to study surface expression of these
molecules, our work in sheep has utilized in situ hy-
bridization to identify expression in a wide range of
cells including B cells (e.g., in bronchus/bronchiole-
associated lymphoid tissue, Fig. 4) and in central ner-
vous system (CNS) microglial cells and neuronal cell
bodies.41
CD1 and Antigen Presentation
Although the precise mechanism for antigen presen-
tation has not currently been elucidated, it is now gen-
erally accepted that CD1 molecules have evolved to
provide an extra arm to the immune response by virtue
of their ability to present lipid/glycolipid-derived and
hydrophobic antigens. The recent resolution of the
crystal structure of mouse CD1d demonstrated a deep
antigen-binding groove, implying that presentation oc-
curs in a fashion broadly similar to that of classical
MHC molecules.56 In simplistic terms, the presentation
of lipid by CD1 molecules can be broadly divided into
two categories: that derived from infectious agents
(principally bacterial and parasitic) and self lipid. Re-
search to date suggests that bacteria-derived antigens
are presented by group 1 CD1 molecules rather than
group 2 molecules.43 Figure 5 illustrates examples of
proposed mechanisms and downstream consequences
of this presentation, whereby presentation of bacterial
antigens elicits IFN# production and a Th1-type re-
sponse, with ultimate killing of infected macrophag-
es14,29,50 (Fig. 5A). In contrast, presentation of self lipid
may be more likely to elicit a Th2-type response, with
resultant rapid production of cytokines by responding
populations of NK T cells (Fig. 5B).
Presentation of foreign lipid
Mycobacteria. In terms of speciﬁc infectious
agents, most research has focused on mycobacterial
disease, with detailed biochemical analysis of the mi-
crobial lipids involved.12,20,32,33 The identiﬁcation of the
capacity for CD1 molecules to bind hydrophobic li-
gands, notably bacteria-derived lipid/glycolipid, has
been extended to show deﬁnitively that CD1 mole-
cules effectively sample mycobacterial glycolipids
from intracellular sites within infected cells.43 Infection
of APCs with Mycobacterium tuberculosis downreg-
ulates the expression of human CD1b, suggesting the
presence of a novel evasion mechanism of M. tuber-
culosis that could contribute to persistence of intracel-
lular infection by avoiding immune recognition.51
Research has only relatively recently turned from
this basic immunologic characterization toward assess-
ment of the role and signiﬁcance of this CD1-mediated
presentation in vivo in naturally occurring disease sit-
uations. In humans, study of the role of CD1 in the
pathogenesis of leprosy has revealed that expression
of CD1 is correlated with effective immunity to My-
cobacterium leprae.46,47 Investigation of CD1 expres-
sion in sheep with ovine paratuberculosis has shown a
similar upregulation of CD1 expression in association
with the tuberculoid form of the disease.38 In addition,
a recent study investigated both the expression of CD1
molecules (group 1) and #$ T cells in a model of ovine
paratuberculosis.4 Levels of #$ T cells increased to a
signiﬁcant level, and a decrease was observed in the
number of CD1 cells in the jejunal Peyer’s patch of
the infected group. Although this decrease was not sig-
niﬁcant, it may represent a mild in vivo illustration of
a downregulation mechanism employed by M. tuber-
culosis.
Overall, these ﬁndings are consistent with a role for
CD1 in ensuring the generation of an effective cell-
mediated immune response against mycobacteria. In
addition to these studies of mycobacterial disease of
humans and ruminants, mice treated with anti-CD1
mAbs show exacerbated tuberculosis lesions compared
with controls.52
Other pathogens. Although the majority of research
has inevitably focused on the potential for CD1 mol-
ecules to present mycobacterial antigens, it seems un-
likely that this family of molecules has been retained
throughout evolution solely to provide a protective
mechanism against this one class of bacteria. Obvious
other candidate organisms would include organisms
with similar structural elements, such as Rhodococcus
and Nocardia. The palmitate hypothesis has been pro-
posed20 whereby palmitate anchors covalently attach
capsular polysaccharides from a variety of organisms
into the groove of CD1. In support of this hypothesis,
preliminary studies have identiﬁed CD1-restricted T-
cell populations that proliferate in response to Hae-
mophilus influenzae type b antigen.19 Other recent
studies have shown that CD1d deﬁciency impairs host
resistance to the spirochaete Borrelia burgdorferi (an
organism containing proinﬂammatory lipid antigen).28
Glycosylphosphatidylinositol (GPI) has been eluted
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Fig. 2. Thymus; horse. Strong staining of cortical thymocytes for group 1 CD1 (mAb CC20). Avidin–biotin–peroxidase
complex method, Mayer’s hematoxylin counterstain. Bar " 50 'm.
Fig. 3. Lymph node; dog. Staining of paracortical dendritic cells for group 1 CD1 (mAb CC20). Avidin–biotin–per-
oxidase complex method, Mayer’s hematoxylin counterstain. Bar " 100 'm.
Fig. 4. Lung; sheep. In situ hybridization using conserved (alpha 3 domain) antisense digoxigenin-labeled riboprobe
showing positive bronchiole–associated lymphoid tissue lymphocytes. Developed using antidigoxigenin alkaline phospha-
tase; nitroblue tetrazolium/bromochloroindelyl phosphate method. Bar " 50 'm.
from murine CD1d,25 and this compound is present in
several protozoan parasites, including Leishmania.
CD1–NK T-cell interactions are involved in regulating
immunogobulin G responses to the GPI-anchored sur-
face antigens of Plasmodium and Trypanosoma.44
These studies suggest that the speciﬁc pathogens iden-
tiﬁed thus far as having an association with CD1-pre-
senting molecules are likely to represent the tip of the
iceberg.
Presentation of self-derived lipid
In addition to the role in certain infectious diseases,
CD1 molecules have also been implicated in other dis-
eases by virtue of their capacity to present nonmicro-
bial lipid. The best example of this presentation is the
CD1 expression associated with human atherosclerotic
plaques.30 CD1 expression in these areas may indicate
a role in the genesis of the lesions and may provide a
mechanism for sustained T-cell activation.
A further area in which CD1 presentation of lipid
has been investigated is in tumors associated with gly-
colipid antigens. More speciﬁcally, the relationship be-
tween the number of inﬁltrating CD1a-positive cells
and prognosis has been investigated in tumors, includ-
ing breast carcinomas, with some descriptions of an
association of these cells with an improved prognosis.
In particular, there is evidence that CD1a-positive cells
may have a role in antigen capture and presentation
within these tumors.5,22
Considering this association with lipid and lipid-re-
lated antigens, it is perhaps not surprising that studies
of CD1 expression in certain CNS diseases have also
identiﬁed upregulation of CD1 in this lipid-rich envi-
ronment. Speciﬁcally, studies on patients with acute
inﬂammatory demyelinating polyradiculoneuropathy
showed upregulation of CD1a and CD1b on endoneu-
rial macrophages and on myelinated nerve ﬁbers.26
Chronic-active multiple sclerosis lesions also show
prominent CD1b immunoreactivity on perivascular in-
ﬂammatory cells and on hypertrophic astrocytes.3
Role of CD1 in Immune-mediated Disease
In addition to the role in presentation of lipid-de-
rived antigens (either lipid from pathogens or inter-
nally derived lipid), a role for CD1 molecules in im-
mune-mediated disease has also been shown. In par-
ticular the two broad areas of allergic/atopic disease
and autoimmune disease have been investigated.
NK T cells reactive with group 2 CD1 molecules
can produce large amounts of IL-4,6,54 thus supporting
the hypothesis that these molecules are involved in al-
lergic diseases by virtue of skewing the immune re-
sponse towards the Th2 pathway (Fig. 5B). Also in
support of this hypothesis, studies on alveolar macro-
phages isolated from asthmatic humans have shown
overexpression of CD1,2 and it has been hypothesized
that both #$ T cells and CD1 expression contribute to
atopic status in some individuals.49
Studies on contact hypersensitivity in sheep have
shown CD1 expression both on and in close associa-
tion with vascular endothelium, consistent with a role
in antigen presentation during the dermatitis reaction.24
In humans, studies on lesions of psoriasis have iden-
tiﬁed overexpression of CD1d in chronic-active
plaques.10 In contrast to the restricted and low level of
expression in normal skin, CD1d expression was in-
duced in these lesions and also in response to physical
trauma and contact sensitizing agents.
With regard to autoimmune disease, most data are
from studies on genetically modiﬁed mice,31,55 e.g., ge-
netically engineered mice predisposed to development
of lupus exhibit CD1-dependant production of auto-
antibody.55 Nevertheless, there is sufﬁcient evidence to
suggest that there may be a role for the CD1 axis in
genuine naturally occurring autoimmune and allergic
disease.
CD1 Expression in Reactive and Neoplastic
Populations
In addition to the role of CD1 as an antigen-pre-
senting molecule and resultant involvement in infec-
tious and immune-mediated disease, expression of
CD1 has also been used to conﬁrm the histogenesis of
certain neoplastic populations. CD1 expression by
neoplastic cells has been demonstrated in canine cu-
taneous histiocytoma, establishing the origin of this
tumor as a Langerhans cell histiocytosis.35 Although
this example illustrates the use of CD1 mAbs for sim-
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Fig. 5. Schematic of different potential roles of group 1 versus group 2 CD1 molecules. Current evidence suggests that
group 1 CD1 recognition is directly involved in removal of infected APCs (A) in contrast to group 2 recognition which
has an indirect regulatory role (B).
plistic cell phenotyping, more recent studies have de-
ﬁned canine cutaneous and systemic histiocytosis as
two clinical manifestations of a reactive population of
CD1-positive dermal dendritic cells, and immune dys-
regulatory mechanisms are thought to be involved in
the genesis of the lesion.1 It is tempting to speculate
that CD1 as a recognized antigen-presenting molecule
expressed on potent APCs (dendritic cells) may be in-
volved in lesion development.
Conclusion
CD1 molecules are an intriguing family of antigen-
presenting molecules whose importance in the patho-
genesis of certain diseases is only beginning to be elu-
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cidated. Although there is much focus currently on
their role in presentation of mycobacteria-derived lip-
ids, it is unlikely that the evolutionary conservation
that is a feature of this family relates to a role solely
as presenters of molecules from such a speciﬁc group
of pathogens. It is more likely that the diseases in
which CD1 molecules have been shown to be impor-
tant represent the tip of the iceberg. Further research
is needed into the relevance of this arm of the immune
response to immune-mediated (in particular autoim-
mune) disease and how these molecules might guide
the immune response along advantageous or detrimen-
tal pathways. This research would be aided by inves-
tigation of CD1 expression patterns in various diseases
in domestic rather than laboratory species, in particular
in view of the recognized dissimilarities between the
rodent CD1 system and those of other veterinary spe-
cies. Many questions pertaining to the CD1 system
remain to be answered. In particular it would be de-
sirable to establish the CD1 status of domestic animals
with the aim of facilitating subsequent investigations
into the role of these molecules in infectious and im-
mune-mediated disease.
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